R&D project coordinator

Michał Wszoła MD, PhD

Project funded by:

European Union from resources of the European Fund on Regional Development, Operational Programme – Intelligent Development 2014-2020. Project realized within the competition of National Centre for research and Development 3/1.1.1/2020 Fast track 3_2020.

Time frame:

January 2021 - June 2023

Project leader:

Sygnis New Technologies sp. z o.o.

Consortium:

Sygnis New Technologies sp. z o.o. and Foundation on Research and Science Development

CREATION OF PRINTING TECHNOLOGY FROM BIOMATERIALS AND CONSTRUCTION OF 3D BIOPRINTER FOR AUTOMATED PRODUCTION OF BIONIC ORGANS

Competition FAST TRACK 3_2020

Aim of the project is to create an innovative at a world scale 3D bioprinter adjusted to clinical research along with complementary set of original bioinks enabling printing of bionic pancreas based on stem cells of a patient undergoing transplantation of this organ. Final purpose of the technology is its use for bioprinting of other human organs for the purpose of transplantations.

During realization of the project, we will continue works on creation of bioink technology and construction of 3D bioprinter for automated manufacturing of bionic organs. Our innovative 3D bioprinter will be the first in the world that can be applied in clinical practice and the idea of construction is its use in hospitals. Through such bioprinter, 3D bioprinting of bionic organs will be possible with the aim to use them in transplantations in case of patients in Poland and the rest of the world.

Our innovative product will facilitate complicated technical medical procedures and most of all, provide new possibilities for creation of personalized organs for research and transplantation. 3D bioprinter could be used by medical and pharmaceutical companies, hospitals, clinics and scientific centers. Its exceptional advantage will be a possibility to produce different types of tissues in one 3D bioprinter, instead of using devices dedicated solely for one specified tissue model.

3D bioprinting technology means shaping spatial structures compounded of living cells kept in bioink, bio-compatible hydro-gel that shall enable creating precise shape of printed object. Depending on the used type of cells, diverse research biological 3D models are obtained.

Project funded by:

Project „CREATION OF PRINTING TECHNOLOGY FROM BIOMATERIALS AND CONSTRUCTION OF 3D BIOPRINTER FOR AUTOMATED PRODUCTION OF BIONIC ORGANS” funded by European Union from resources of the European Fund on Regional Development, Operational Programme – Intelligent Development 2014-2020. Project realized within the competition of National Centre for research and Development 3/1.1.1/2020 Fast track 3_2020.